Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2006-03-07
2006-03-07
Leith, Patricia (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
07008649
ABSTRACT:
Pharmaceutical compositions containing plant essential oil compounds, natural or synthetic, or mixtures or derivatives thereof, with one or more signal transduction modulators, for the prevention and treatment of cancer.
REFERENCES:
patent: 4261989 (1981-04-01), Sasaki et al.
patent: 4751224 (1988-06-01), Agarwal et al.
patent: 5322844 (1994-06-01), Aranda et al.
patent: 5387584 (1995-02-01), Schnur
patent: 5595756 (1997-01-01), Bally et al.
patent: 5602184 (1997-02-01), Myers et al.
patent: 5626854 (1997-05-01), Ichii et al.
patent: 5795910 (1998-08-01), Giese et al.
patent: 5830887 (1998-11-01), Kelly
patent: 5911995 (1999-06-01), Uckun
patent: 6028061 (2000-02-01), Bernfield et al.
patent: 6147107 (2000-11-01), Dent et al.
patent: 6268163 (2001-07-01), Kongsbak et al.
patent: 3829200 (1990-01-01), None
patent: 0 448 029 (1991-03-01), None
patent: 2 706 771 (1994-12-01), None
patent: 2 151 924 (1985-07-01), None
patent: 2 151 924 (1985-07-01), None
patent: WO 93/09770 (1993-05-01), None
patent: WO 98/48790 (1998-11-01), None
Gura, T. Systems for Identifying new Drugs are Often Faulty; Science, vol. 278, 1997, pp. 1041-1042.
Saeed et al. EUGENOL: a Dual Inhibitor of Platelet-Activating Factor and Arachidonic Acid Metabolism; Phytomedicine (1995), 2 (1), 23-28, 2 page CAPLUS Abstract provided.
Clardiello et al. Interactions Between the Epidermal Growth Factor Receptor and Type I Protein Kinase A: Biological Significance and Therapeutic Implications; Clinical Cancer Research vol. 4, pp. 821-828.
Yokota et al. Suppressed Mutagenicity of Benzo[a]pyrene by the Liver S9 Fraction and Microsomes from Eugenol Treated Rats; Mutation Research, 172 pp. 231-236.
Azuine, M.A. et al., “Chemopreventive efficancy of betal leaf extract and its constituents on 7,12-dimethylbenz(a)anthracene induced carcinogenesis and their effect on drug detoxification sustem in mouse skin”,Indian Journal of Experimental Biology, 29(4);346-351 (1991).
Baker, P.R. et al., “Cell signaling and basement membrane degradation by breast cancer cells”,British Journal of Cancer, 69(Suppl. 21): 18 (1994).
Kinoshita, E. et al., “Activation of MAP kinase cascade induced by human pancreatic phospholipase A2in a human pancreatic cancer cell line”,FEBS Letters, 407(3):343-346 (1997).
Nayfield, S.G., “Tamoxifen's role in chemoprevention of breast cancer: an update”,Journal of Cellular Biochemistry, Suppl. 22:42-50 (1995).
Strobl, J.S. et al., “Mitogenic signal transduction in human breast cancer cells”,General Pharmacology, 26(8):1643-1649.
Tzanakakis, G.N. et al., “Inhibition of hepatic metastasis from a human pancreatic adenocarcinoma (RWP-2) in the nude mouse by prostacyclin, forskolin, and ketoconazole”,Cancer, 65(3):446-451 (1990).
Yokota, H. et al., “Enhancement of UDP-glucuronyltransferase, UDP-glucose dehydrogenase, and glutathione S-transferase activities in rat liver by dietary administration of eugenol”,Biochemical Pharmacology, 37(5):799-802 (1988).
Bardon, S. et al., “Monoterpenes Inhibit Cell Growth, Cell Cycle Progression, and Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines”,Nutrition and Cancer, 32(1):1-7 (1998).
Berthois, Y. et al., “Phenol Red in Tissue Cculture Media is a Weak Estrogen: Implications Concerning the Study of Eestrogen-Responsive Cells in Culture”,Proc. Natl. Acad. Sci.,83:2496-2500 (Apr. 1986).
Ciardiello, F. et al., “Interactions between the Epidermal Growth Factor Receptor and Type I Protein Kinase A: Biological Significance and Therapeutic Implications”,Clinical Cancer Research, 4:821-828 (Apr. 1998).
Davis, D. et al, “Medical Hypothesis: Xenoestrogens As Preventable Causes of Breast Cancer”,Env. Health Per.,101(5):372-377 (Oct. 1993).
Dees, C. et al., “Dietary Estrogens Stimulate Human Breast Cells to Enter the Cell Cycle”,Environ. Health Perspect.,105(Suppl 3):633-636 (Apr. 1997).
Dewailly, E. et al., “High Organochlorine Body Burden in Women With Estrogen Receptor-Positive Breast Cancer”,J. Nati. Cancer Inst.,86(3):232-234.
Gura, T., “Systems for Identifying New Drugs Are Often Faulty”,Science, 278:1041-1042 (Nov. 1997).
Harris, J. et al., “Breast Cancer”,New England J. of Med.,327(5):319-318 (1992).
Henderson, B. et al., “Hormonal Chemoprevention of Cancer in Women”,Science, 259:633-638 (1993).
Hoffman, M., “New Clue Found to Oncogene's Role in Breast Cancer”,Science, 256:1129 (1992).
Jobling, S. et al., “A Variety of Environmental Persistent Chemicals, Including Some Phthalate Plasticizers, Are Weakly Estrogenic”,Envir. Health. Per.,103:582-587 (1995).
Kim et al., “Antiananphylactic Properties of Eugenol”, Pharma. Res., 36(6):475-480 (1997).
Miller, F. et al., “Xenograft Model of Progressive Human Proliferative Breast Disease”,J. Natl. Cancer Inst.,85(21):1725-1731 (1993).
Mussalo-Rauhamaa, H. et al., “Occurrence of Beta-Hexachlorocyclohexane in Breast Cancer Patients”,Cancer, 66:2124-2128 (1990).
Nelson, J. et al., “Estrogenic Activities of Chlorinated Hydrocarbons”,J. Tox. Envir. Health, 4:325-339 (1978).
Oita et al., “Opthalmic Pharmaceutical”, CAPLUS 427328, Patent No. RO84026 (1985) ABSTRACT.
Osborne, C. K. et al., “Antagonism between Epidermal Growth Factor and Phorbol Ester Tumor Promoters in Human Breast Cancer Cells”,J. Clin. Invest.,67:943-951 (1981).
Reese, J., et al., “Differential DNA-Binding Abilities of Estrogen Receptor Occupied With Two Clases of Antiestrogens: Studies Using Human Estrogen Receptor Overexpressed in Mammalian Cells”,Nucleic Acids Res.,19(23):6595-6602.
Saeed et al., Eugenol: A Dual Inhibitor of Platelet-Activating Factor and Arachidonic Acid Metabolism:Phytomedicine, 2(1):23-28 (1995).
Soto, A. M. et al., “The Role of Estrogens on the Proliferation of Human Breast Tumor Cells (MCF-7)”,J. Steroid Biochem.,23(1):87-94 (1985).
Sukumaran et al., “Inhibition of Tumour Promotion in Mice by Eugenol”,Indian J. Physiol. Pharmacol.,38(4):306-308.
Wolff, M. et al., “Blood Levels of Organochlorine Residues and Risk of Breast Cancer”,J. Natl. Cancer Inst.,85(8):648-652 (1993).
Yokota, H. et al., “Suppressed Mutagenicity of Benzo[α]pyrene by the Liver S9 Fraction and Microsomes from Eugenol-Treated Rats”,Mutation Research, 172:231-236 (1986).
Sylvie Bardon, et al., Monoterpenes Inhibit Cell Growth, Cell Cycle Progression, and Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines, Nutrition and Cancer, vol. 32, No. 1, 1998, pp. 1-7.
Bessette Steven M.
Enan Essam E.
Ecosmart Techonlogies, Inc.
Leith Patricia
Nixon & Vanderhye P.C.
LandOfFree
Cancer treatment composition and method using natural plant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer treatment composition and method using natural plant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer treatment composition and method using natural plant... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3541918